
LFVN Valuation
LifeVantage Corp
LFVN Relative Valuation
LFVN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LFVN is overvalued; if below, it's undervalued.
Historical Valuation
LifeVantage Corp (LFVN) is now in the Fair zone, suggesting that its current forward PE ratio of 7.12 is considered Fairly compared with the five-year average of 9.16. The fair price of LifeVantage Corp (LFVN) is between 3.99 to 12.38 according to relative valuation methord.
Relative Value
Fair Zone
3.99-12.38
Current Price:7.40
Fair
7.12
PE
1Y
3Y
5Y
Trailing
Forward
3.75
EV/EBITDA
LifeVantage Corp. (LFVN) has a current EV/EBITDA of 3.75. The 5-year average EV/EBITDA is 4.26. The thresholds are as follows: Strongly Undervalued below -0.87, Undervalued between -0.87 and 1.70, Fairly Valued between 6.82 and 1.70, Overvalued between 6.82 and 9.39, and Strongly Overvalued above 9.39. The current Forward EV/EBITDA of 3.75 falls within the Historic Trend Line -Fairly Valued range.
5.27
EV/EBIT
LifeVantage Corp. (LFVN) has a current EV/EBIT of 5.27. The 5-year average EV/EBIT is 6.49. The thresholds are as follows: Strongly Undervalued below -0.84, Undervalued between -0.84 and 2.82, Fairly Valued between 10.15 and 2.82, Overvalued between 10.15 and 13.82, and Strongly Overvalued above 13.82. The current Forward EV/EBIT of 5.27 falls within the Historic Trend Line -Fairly Valued range.
7.40
PS
LifeVantage Corp. (LFVN) has a current PS of 7.40. The 5-year average PS is 0.45. The thresholds are as follows: Strongly Undervalued below -0.97, Undervalued between -0.97 and -0.26, Fairly Valued between 1.15 and -0.26, Overvalued between 1.15 and 1.86, and Strongly Overvalued above 1.86. The current Forward PS of 7.40 falls within the Strongly Overvalued range.
4.28
P/OCF
LifeVantage Corp. (LFVN) has a current P/OCF of 4.28. The 5-year average P/OCF is 4.87. The thresholds are as follows: Strongly Undervalued below -0.98, Undervalued between -0.98 and 1.95, Fairly Valued between 7.79 and 1.95, Overvalued between 7.79 and 10.72, and Strongly Overvalued above 10.72. The current Forward P/OCF of 4.28 falls within the Historic Trend Line -Fairly Valued range.
9.86
P/FCF
LifeVantage Corp. (LFVN) has a current P/FCF of 9.86. The 5-year average P/FCF is -1.95. The thresholds are as follows: Strongly Undervalued below -29.33, Undervalued between -29.33 and -15.64, Fairly Valued between 11.74 and -15.64, Overvalued between 11.74 and 25.42, and Strongly Overvalued above 25.42. The current Forward P/FCF of 9.86 falls within the Historic Trend Line -Fairly Valued range.
LifeVantage Corp (LFVN) has a current Price-to-Book (P/B) ratio of 2.83. Compared to its 3-year average P/B ratio of 3.67 , the current P/B ratio is approximately -22.91% higher. Relative to its 5-year average P/B ratio of 3.22, the current P/B ratio is about -12.17% higher. LifeVantage Corp (LFVN) has a Forward Free Cash Flow (FCF) yield of approximately 0.09%. Compared to its 3-year average FCF yield of 7.65%, the current FCF yield is approximately -98.79% lower. Relative to its 5-year average FCF yield of 10.31% , the current FCF yield is about -99.10% lower.
2.83
P/B
Median3y
3.67
Median5y
3.22
0.09
FCF Yield
Median3y
7.65
Median5y
10.31
Competitors Valuation Multiple
The average P/S ratio for LFVN's competitors is 5.87, providing a benchmark for relative valuation. LifeVantage Corp Corp (LFVN) exhibits a P/S ratio of 7.40, which is 26.13% above the industry average. Given its robust revenue growth of 0.73%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of LFVN decreased by 49.35% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 3.87 to 4.53.
The secondary factor is the Revenue Growth, contributed 0.73%to the performance.
Overall, the performance of LFVN in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

GOCO
Gohealth Inc
3.390
USD
-3.97%

ORN
Orion Group Holdings Inc
10.150
USD
-1.36%

TATT
TAT Technologies Ltd
38.920
USD
+4.48%

PBPB
Potbelly Corp
0
USD
+0.06%

MVIS
MicroVision Inc
1.070
USD
+1.90%

TTSH
Tile Shop Holdings Inc
6.240
USD
-0.48%

TSHA
Taysha Gene Therapies Inc
3.830
USD
-2.30%

XOMA
Xoma Royalty Corp
33.190
USD
-2.58%

COFS
ChoiceOne Financial Services Inc
29.370
USD
-0.14%

PDLB
Ponce Financial Group Inc
15.080
USD
+3.43%
FAQ
Is LifeVantage Corp (LFVN) currently overvalued or undervalued?
LifeVantage Corp (LFVN) is now in the Fair zone, suggesting that its current forward PE ratio of 7.12 is considered Fairly compared with the five-year average of 9.16. The fair price of LifeVantage Corp (LFVN) is between 3.99 to 12.38 according to relative valuation methord.









